Pacific Northwest Endovascular Conference (PNEC)

March 4, 2016 — Boston Scientific has received U.S. Food and Drug Administration (FDA) approval for the Acuity X4 quadripolar left ventricular (LV) leads.

Recent results from the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST) are evidence that stenting will continue to remain competitive with surgical treatment, said an analyst with research and consulting firm GlobalData. CREST data has shown patients with severe carotid artery stenosis suffered similar rates of adverse events in both stenting and endarterectomy procedures.

W. L. Gore & Associates (Gore) announced the availability of a new 7.5 cm length of the Gore Viabahn Endoprosthesis with heparin bioactive surface. Gore developed this size in response to physician needs for certain clinical situations. The device is now available in six lengths: 2.5, 5, 7.5, 10, 15 and 25 cm.

Brain imaging may accurately identify patients likely to benefit from stroke clot removal instead of relying on the time since symptoms began as an indicator of treatment eligibility. The hypothesis was derived from research presented at the American Stroke Association's International Stroke Conference 2016.

Last August, Children’s Hospital Los Angeles (CHLA) cardiologists confirmed the heart of a 27-week-old fetus suffered from a critical cardiac condition that prevented blood returning from the fetus’s lungs from circulating back into the body.

Vital Connect debuted the VitalPatch biosensor at the 2016 Healthcare Information and Management Systems Society (HIMSS) conference and exhibition, Feb. 29-March 4 in Las Vegas.

Avinger Inc. announced the company has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for an enhanced version of its Pantheris lumivascular atherectomy system for the treatment of peripheral artery disease (PAD).

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now